HIGHLIGHTS
- who: Luca Castagna from the Center, United States University of Bologna, Italy have published the research: The place of allogeneic stem cell transplantation in aggressive B-cell non-Hodgkin lymphoma in the era of CAR-T-cell therapy, in the Journal: (JOURNAL)
- what: This research era has witnessed an increasing understanding of the molecular abnormalities present in lymphoma cells, and based Frontiers in Medicine frontiersin.org 10.3389/fmed.2022.1072192 on this knowledge, more precise therapies have been developed. In this trial, the NRM incidence was reported for patients receiving MRD or MUD transplants . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.